Stem Cell Gene Therapy for Sickle Cell Anemia - Donald Kohn

CIRM has funded a $9 million disease team to develop a more effective and safer bone marrow transplant to treat sickle cell disease. The team is led by Dr. Donald Kohn, director of the Human Gene Medicine Program at UCLA, a scientist with the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and a professor of microbiology and pediatrics. Kohn updated the CIRM Governing Board on May 05, 2011 about this team's progress. Kohn was introduced by Bert Lubin, a CIRM Governing Board member and president of the Children's Hospital & Research Center of Oakland and by Robert Klein, chair emeritus of the CIRM Governing Board.

For more information see our sickle cell disease fact sheet


Disease Programs

Learn about how CIRM-funded stem cell research could generate treatments for many chronic diseases and injuries.

See disease fact sheets

CIRM Stem Cell Blog